Contemporary Incidence and Survival of Lung Neuroendocrine Neoplasms
The incidence of lung NENs has increased over 20 years, mostly associated with stage I disease. Prolonged OS was observed after lung NEN diagnosis. Patients with typical lung NET and stage I disease were more likely to die of causes other than lung cancer after 1 and 3 years, respectively. These data are important to direct efforts in care, research, and patient counseling.
Authors
- Léamarie Meloche‐Dumas (ORCID: https://orcid.org/0000-0002-4498-9952)
- Julie Hallet (ORCID: https://orcid.org/0000-0001-5108-1072)
- Wing C. Chan (ORCID: https://orcid.org/0000-0002-6243-6008)
- Sten Myrehaug (ORCID: https://orcid.org/0000-0002-5765-1969)
- Simron Singh (ORCID: https://orcid.org/0000-0002-5179-7043)
- Mathieu Rousseau
- Elliot Wakeam
- Anna Gombay
Institutions
- Ontario Institute for Cancer Research (CA)
- Sunnybrook Health Science Centre (CA)
- University of Toronto (CA)
- Cancer Care Ontario (CA)
- Sunnybrook Research Institute
- McGill University (CA)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-10-02
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.35125
- Citations
- 1
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Ontario Ministry of Health and Long-Term Care
- Ipsen
- Canadian Institutes of Health Research